The probable reason might be as follows: MiR‐34a was known to regulate lipid metabolism via suppressing the expression of SIRT1; meanwhile, dyslipidemia was one of main factors causing these comorbidities.30, 41. This evidence concerns the gene SIRT1 and metabolic syndrome.